Broker Ratings

Doximity, Inc. Share Price Target ‘$25.92’, now -8.3% Downside Potential

Doximity, Inc. with ticker code (DOCS) have now 12 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between $31.00 and $21.00 suggesting an average Analsyt target price of $25.92. Given that the stocks previous close was at $28.28 this now indicates there is a potential downside of -8.3%. It’s also worth noting that there is a 50 day moving average of $23.97 and the 200 day MA is $28.29. The total market capitalization for the company now stands at 5.28B. The stock price for the company is currently $28.42 USD

The potential market cap would be $4,842,590,295 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 49, revenue per share of $2.32 and a 8.76% return on assets.

Doximity, Inc. provides a digital platform for United States (U.S) medical professionals. The Company’s cloud-based platform provides tools to its members, which help them to collaborate with colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with medical news and research, and manage careers. The Company supports physicians in practice of medicine with mobile and clinical workflow tools, such as voice and video telehealth, secure messaging and digital faxing. The Company’s platform offers marketing, hiring, and telehealth solutions. Its marketing solutions enable pharmaceutical and health system customers to get content, services, and peer connections to medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its telehealth solutions consist of software tools that include voice and video dialers, designed to connect patients with care providers.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Doximity, Inc. (DOCS): Investor Outlook on a $12.66 Billion Healthcare Innovator with a Strong Upside

    Doximity, Inc. (DOCS), a leading player in the Health Information Services industry, has become a pivotal digital platform for healthcare professionals in the United States. With a market capitalization of

    Doximity, Inc. (DOCS) Stock Analysis: Understanding the 6.86% Potential Upside for Investors

    Doximity, Inc. (DOCS), a leader in the health information services sector, has carved out a unique niche in the digital healthcare landscape. With a market capitalization of $12.29 billion, Doximity

    Dr. Martens appoints Berenberg as Joint Corporate Broker

    Dr. Martens plc has appointed Berenberg as a joint corporate broker with immediate effect, working alongside Investec and Goldman Sachs.

    Doximity, Inc. (DOCS) Stock Analysis: Revenue Growth and Analyst Ratings Boost Investor Interest

    Doximity, Inc. (NYSE: DOCS), a leading U.S.-based digital platform for medical professionals, has captured the attention of investors in the healthcare sector. With a robust market capitalization of $13.72 billion,

    Dr. Martens Plc expands into UAE and Latin America through new partnerships

    Dr. Martens has signed a distribution deal with Beside Group to enter the UAE market for the first time and partnered with Crosby in Latin America, which has opened stores

    Doximity, Inc. (DOCS) Stock Analysis: Strong Buy Ratings Amid Robust Revenue Growth

    Doximity, Inc. (NASDAQ: DOCS) stands out in the healthcare sector as a premier digital platform designed for medical professionals. With a market capitalization of $13.94 billion, Doximity has carved a

      Search

      Search